CVT 0.00% $1.12 comvita limited ordinary shares

Ann: MEETING: CVT: Director Fee Resolution at 2015 Annual Shareholder Meeting

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 2
    • Release Date: 09/07/15 11:18
    • Summary: MEETING: CVT: Director Fee Resolution at 2015 Annual Shareholder Meeting
    • Price Sensitive: No
    • Download Document  2.05KB
    					CVT
    09/07/2015 11:18
    MEETING
    NOT PRICE SENSITIVE
    REL: 1118 HRS Comvita Limited
    
    MEETING: CVT: Director Fee Resolution at 2015 Annual Shareholder Meeting
    
    Resolution 6 to be considered at the Annual Shareholders Meeting on 23 July,
    proposes that director fees be increased over a two year period as prescribed
    in the Resolution.  Following representations from the New Zealand
    Shareholders Association, the Board of Comvita has agreed that the increase
    of director fees proposed for the 2nd year (2016-2017) would only be applied
    if Comvita's net profit after tax per share increases by a minimum of 20% for
    the year ended 31 March 2016.
    
    # Ends #
    
    For further information:
    Neil Craig, Chairman, 021 731 509
    
    Background information
    About Comvita (www.comvita.com)
    Comvita (NZX:CVT) is a global natural health company committed to the
    development of innovative products, backed by ongoing investment in
    scientific research. We are the world leaders in Manuka (leptospermum) honey
    and fresh-picked Olive Leaf Extract, which are at the core of the Comvita
    product range.
    
    We have approximately 50% of honey supply under direct ownership or control,
    with the balance of supply from long term contractual and partnership
    arrangements. Comvita pioneered the development and use of medical grade
    Manuka honey and was the first to receive FDA approval (2007). We partner
    with US wound care company Derma Sciences, Inc. (NASDAQ:DSCI), the global
    licensee for Medihoney specialist wound care products, which are used in
    hospitals and medical centres around the world. Comvita's freshly picked
    Olive Leaf Extract is grown, harvested, extracted and bottled at the world's
    largest specialised olive leaf grove, with over one million olive trees.
    
    Comvita sells into more than 18 countries through a network of our own
    branded retail locations, online (seven country specific e-commerce websites)
    and third-party outlets. We have over 500 staff located in New Zealand,
    Australia, Hong Kong, Japan, Taiwan, South Korea, the United Kingdom and the
    USA.
    End CA:00266821 For:CVT    Type:MEETING    Time:2015-07-09 11:18:45
    				
 
watchlist Created with Sketch. Add CVT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.